Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- ChecktodayChange DetectedA new revision entry v3.6.2 was added to the record history, and the previous entry v3.6.0 was removed, indicating an update to the page's revision history.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe history now shows recruitment has ended with 'No longer looking for participants', signalling cessation of enrollment. A new revision entry 'Revision: v3.6.0' was added, replacing the previous 'Revision: v3.5.5' in the version history.SummaryDifference0.4%

- Check22 days agoChange DetectedA new history revision (v3.5.5) has been added to the study record’s Version History, replacing the previous revision (v3.5.4).SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the previous revision label v3.5.3 was removed from the visible changes.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a system/site version change rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study history page.SummaryDifference0.1%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.